logo-loader

Pharmaxis Ltd

Receive alerts
Market:
ASX
Market Cap:
$102.61 m
Price
0.26 AUD
Change
0.00%
52 weeks high
0.31
52 weeks low
0.18

In brief

Pharmaxis Ltd (ASX:PXS) is a specialty pharmaceutical company focused on the development of new products for the diagnosis and treatment of chronic respiratory and immune disorders.

Deep dive We explore the investor case for growth companies

Snapshot

The company’s CEO Gary Phillips has presented during the 2019 AusBiotech Conference in Melbourne.